Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease
Sneha Mantri, Michelle Fullard, Shelly L. Gray, et al.
JAMA Neurology (2018) Vol. 76, Iss. 1, pp. 41-41
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Parkinson disease-associated cognitive impairment
Dag Aarsland, Lucia Batzu, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 754
The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Daniel Weintraub, Eugenia Mamikonyan
American Journal of Geriatric Psychiatry (2019) Vol. 27, Iss. 9, pp. 998-1018
Open Access | Times Cited: 130
Anticholinergic Drugs in Geriatric Psychopharmacology
Jorge López‐Álvarez, Julia Sevilla‐Llewellyn‐Jones, Luis Agüera‐Ortiz
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 111
Ethnic Variation in the Manifestation of Parkinson’s Disease: A Narrative Review
Aaron Ben-Joseph, Charles R. Marshall, Andrew J. Lees, et al.
Journal of Parkinson s Disease (2019) Vol. 10, Iss. 1, pp. 31-45
Open Access | Times Cited: 107
Delivery of Biomimetic Liposomes via Meningeal Lymphatic Vessels Route for Targeted Therapy of Parkinson’s Disease
Jing Liu, Duyang Gao, Di Hu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 23
Approach to Cognitive Impairment in Parkinson’s Disease
Qiang Zhang, Georgina M. Aldridge, Nandakumar S. Narayanan, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1495-1510
Open Access | Times Cited: 54
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
Ramón Cacabelos
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3059-3059
Open Access | Times Cited: 48
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease
Ramón Cacabelos
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 8, pp. 673-701
Closed Access | Times Cited: 41
Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?
Matthew J. Barrett, Lana Sargent, Huma Nawaz, et al.
Movement Disorders Clinical Practice (2021) Vol. 8, Iss. 8, pp. 1181-1188
Open Access | Times Cited: 39
Racial and Ethnic Disparities in Parkinson Disease
Whitley W. Aamodt, Allison W. Willis, Nabila Dahodwala
Neurology Clinical Practice (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 15
Racial and Ethnic Differences in Health-Related Quality of Life for Individuals With Parkinson Disease Across Centers of Excellence
Daniel G. Di Luca, Sheng Luo, Hongliang Liu, et al.
Neurology (2023) Vol. 100, Iss. 21
Open Access | Times Cited: 14
Neuropsychiatric Manifestations in Parkinson Disease
Daniel Weintraub, Julia Gallagher, Matthew Stern
Cambridge University Press eBooks (2025), pp. 155-165
Closed Access
Identifying a list of healthcare ‘never events’ to effect system change: a systematic review and narrative synthesis
Cara Bowman, Ria De Gorter, Joanna Zaslow, et al.
BMJ Open Quality (2023) Vol. 12, Iss. 2, pp. e002264-e002264
Open Access | Times Cited: 11
New horizons in Parkinson’s disease in older populations
Jagadish K. Chhetri, Shanshan Mei, Chaodong Wang, et al.
Age and Ageing (2023) Vol. 52, Iss. 10
Closed Access | Times Cited: 11
Parkinson’s Disease in African Americans: A Review of the Current Literature
Meagan Bailey, Sharlet Anderson, Deborah A. Hall
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 3, pp. 831-841
Open Access | Times Cited: 30
Ethnicity and Parkinson’s Disease: Motor and Nonmotor Features and Disease Progression in Latino Patients Living in Rural California
Aline Duarte Folle, Marie Flores, Cynthia Kusters, et al.
The Journals of Gerontology Series A (2023) Vol. 78, Iss. 7, pp. 1258-1268
Open Access | Times Cited: 9
Clinical Non-Motor Phenotyping of Black and Asian Minority Ethnic Compared to White Individuals with Parkinson’s Disease Living in the United Kingdom
Anna Sauerbier, Anette Schrag, Richard G. Brown, et al.
Journal of Parkinson s Disease (2020) Vol. 11, Iss. 1, pp. 299-307
Open Access | Times Cited: 25
Anticholinergics May Carry Significant Cognitive and Gait Burden in Parkinson's Disease
Roopa Rajan, Arti Saini, Bhawna Verma, et al.
Movement Disorders Clinical Practice (2020) Vol. 7, Iss. 7, pp. 803-809
Open Access | Times Cited: 23
The inappropriate use of proton pump inhibitors and its associated factors among community-dwelling older adults
Mohammad Rababa, Abeer M. Rababa’h
Heliyon (2021) Vol. 7, Iss. 7, pp. e07595-e07595
Open Access | Times Cited: 19
Spatial and demographic disparities in short stature among school children aged 7–18 years: a nation-wide survey in China, 2014
Jia Ma, Tao Pei, Fen Dong, et al.
BMJ Open (2019) Vol. 9, Iss. 7, pp. e026634-e026634
Open Access | Times Cited: 17
Frequency of and risk factors for potentially inappropriate medication use in Parkinson’s disease
Danielle S. Abraham, Thanh Phuong Pham Nguyen, Sean Hennessy, et al.
Age and Ageing (2020) Vol. 49, Iss. 5, pp. 786-792
Open Access | Times Cited: 15
Anticholinergic Medication Burden in Parkinson’s Disease Outpatients
Huma Nawaz, Lana Sargent, Helengrace Quilon, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 2, pp. 599-606
Open Access | Times Cited: 13
Racial/ethnic disparities in dementia incidence, outcomes, and health‐care utilization
Jay B. Lusk, Cassie B. Ford, Amy G. Clark, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 6, pp. 2376-2388
Closed Access | Times Cited: 8
Current concepts in treating mild cognitive impairment in Parkinson's disease
Jay S. Schneider, Sandhya Kortagere
Neuropharmacology (2021) Vol. 203, pp. 108880-108880
Closed Access | Times Cited: 11
AChE activity self-breathing control mechanisms regulated by H2Sn and GSH: Persulfidation and glutathionylation on sulfhydryl after disulfide bonds cleavage
Yanwen Zhu, Zhaoliang Hu, Yunen Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129117-129117
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top